[Immunotherapy of allergic rhinitis without allergens? : new options for immunomodulation by vaccination with virus-like particles and CpG motifs].

about

Adjuvants are Key Factors for the Development of Future Vaccines: Lessons from the Finlay Adjuvant Platform.Allergen immunotherapy in allergic rhinitis: current use and future trends.Clinical use of adjuvants in allergen-immunotherapy.

P2860

Q37353525-27D6B683-D879-46F8-BAC9-14F9AA0C104A Q38680655-965053FB-1080-4CA6-9F43-AFCAD5CBB9B9 Q38761412-5F25F9E8-3642-45F6-9B96-FEB764E50C65

P2860

[Immunotherapy of allergic rhinitis without allergens? : new options for immunomodulation by vaccination with virus-like particles and CpG motifs].

Item

http://www.wikidata.org/entity/Q43962396

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

[Immunotherapy of allergic rhi ...... ike particles and CpG motifs].

@en

[Immunotherapy of allergic rhi ...... ike particles and CpG motifs].

@nl

type

Item

label

[Immunotherapy of allergic rhi ...... ike particles and CpG motifs].

@en

[Immunotherapy of allergic rhi ...... ike particles and CpG motifs].

@nl

prefLabel

[Immunotherapy of allergic rhi ...... ike particles and CpG motifs].

@en

[Immunotherapy of allergic rhi ...... ike particles and CpG motifs].

@nl

P1476

[Immunotherapy of allergic rhi ...... ike particles and CpG motifs].

@en

P2093

G Senti

http://www.w3.org/2001/XMLSchema#string

J Willers

http://www.w3.org/2001/XMLSchema#string

L Klimek

http://www.w3.org/2001/XMLSchema#string

P Schendzielorz

http://www.w3.org/2001/XMLSchema#string

T M Kündig

http://www.w3.org/2001/XMLSchema#string

P2860

Eat dirt: CpG DNA and immunomodulation of asthma

Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen).

CpG DNA as a vaccine adjuvant.

T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic diseases.

Mechanisms of allergen specific immunotherapy--T-cell tolerance and more.

Update on the current status of peptide immunotherapy.

Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial.

The coming of age of virus-like particle vaccines.

Immunotherapy of allergic rhinitis: new therapeutic opportunities with virus-like particles filled with CpG motifs.

[Mechanism of action of nasal glucocorticosteroids in the treatment of allergic rhinitis. Part 2: Practical aspects of application].

P2888

s00106-013-2761-9

P304

826-833

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00106-013-2761-9

http://www.w3.org/2001/XMLSchema#string

P407

Af-Jarmal

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24127047

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

[Immunotherapy of allergic rhinitis without allergens? : new options for immunomodulation by vaccination with virus-like particles and CpG motifs].

about

P2860

P2860

[Immunotherapy of allergic rhinitis without allergens? : new options for immunomodulation by vaccination with virus-like particles and CpG motifs].

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P921